Aptevo Therapeutics Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Aptevo Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2015 to Q3 2024.
  • Aptevo Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$5.1M, a 19.5% increase year-over-year.
  • Aptevo Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$23.7M, a 46.9% decline year-over-year.
  • Aptevo Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$17.4M, a 317% decline from 2022.
  • Aptevo Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $8.03M.
  • Aptevo Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$28.5M, a 60.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$23.7M -$5.1M +$1.23M +19.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$25M -$5.88M +$2.07M +26% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$27M -$6.83M -$9.61M -346% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$17.4M -$5.9M -$1.26M -27.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$16.2M -$6.33M +$1.31M +17.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$17.5M -$7.95M -$36M -128% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 $18.5M $2.77M +$10.5M Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 $8.03M -$4.64M +$1.63M +26% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $6.4M -$7.64M -$647K -9.25% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $7.04M $28M +$35.9M Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$28.9M -$7.7M -$441K -6.08% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$28.5M -$6.27M +$781K +11.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$29.2M -$7M -$206K -3.03% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$29M -$7.93M -$1.13M -16.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$27.9M -$7.26M -$10.2M -350% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$17.8M -$7.05M +$1.12M +13.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$18.9M -$6.79M +$133K +1.92% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$19M -$6.8M +$6.53M +49% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$25.5M $2.9M +$14.9M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-12
Q4 2019 -$40.4M -$8.17M +$5.96M +42.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$46.4M -$6.92M +$5.64M +44.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$52M -$13.3M -$188K -1.43% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$51.9M -$12M +$1.84M +13.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$53.7M -$14.1M -$4.37M -44.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-25
Q3 2018 -$49.3M -$12.6M -$50.4M -133% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $1.11M -$13.1M -$1.96M -17.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $3.06M -$13.9M -$3.91M -39.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $6.97M -$9.76M +$5.19M +34.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $1.79M $37.9M +$110M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$108M -$11.2M +$1.65M +12.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$109M -$9.95M +$2.94M +22.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$112M -$14.9M +$2.95M +16.5% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-31
Q3 2016 -$115M -$71.7M -$59.1M -466% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$56.3M -$12.8M +$4.88M +27.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$61.2M -$12.9M -$1.87M -16.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$59.3M -$17.9M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$12.7M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-31
Q2 2015 -$17.7M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-31
Q1 2015 -$11M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.